Squarepoint’s Globus Medical GMED Stock Holding History

Squarepoint’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,600	Closed	-$314K	–	4523
2025 Q4	$314K	Buy	+3,600	New	+$273K	﹤0.01%	3566

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Squarepoint's GMED Position: Q3 2025 in Review

Squarepoint sold out of Globus Medical (GMED) in Q3 2025, closing a stake of 232,384 shares — an estimated $13.4M sold.

Squarepoint first reported a position in GMED in Q4 2016 and held it in 27 quarters. The position peaked at $13.7M in Q2 2025. 489 funds tracked by Wall St. Rank hold GMED as of Q3 2025.

Squarepoint reported no remaining Globus Medical position as of Q3 2025 after selling out during the quarter.
Squarepoint sold 232,384 Globus Medical shares in Q3 2025, an estimated $13.4M.
Squarepoint first reported a position in Globus Medical in Q4 2016 and held it in 27 quarters.
Squarepoint's Globus Medical position peaked at $13.7M in Q2 2025.
489 funds tracked by Wall St. Rank held Globus Medical as of Q3 2025.

Based on Squarepoint's 13F filing for Q3 2025, filed 14 Nov 2025.